These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33342788)

  • 1.
    Putra A; Riwanto I; Putra ST; Wijaya I
    J Cancer Res Ther; 2020; 16(6):1302-1308. PubMed ID: 33342788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Rotenone-Treated Human Breast Cancer Stem Cell Survival Using Survivin Inhibitor YM155 is Associated to Oxidative Stress Modulation.
    Syahrani RA; Yunita E; Wanandi SI
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2631-2637. PubMed ID: 32986362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.
    Wanandi SI; Limanto A; Yunita E; Syahrani RA; Louisa M; Wibowo AE; Arumsari S
    PLoS One; 2020; 15(11):e0240020. PubMed ID: 33211707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scutellarin, a flavonoid compound from Scutellaria barbata, suppresses growth of breast cancer stem cells in vitro and in tumor-bearing mice.
    Ma H; Yue GG; Lee JK; Gao S; Yuen KK; Cheng W; Li X; Lau CB
    Phytomedicine; 2024 Jun; 128():155418. PubMed ID: 38518647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant protein TmSm(T34A) can inhibit proliferation and proapoptosis to breast cancer stem cells(BCSCs) by down-regulating the expression of Cyclin D1.
    Ma X; Zhang Y; Kang Y; Li L; Zheng W
    Biomed Pharmacother; 2016 Dec; 84():373-381. PubMed ID: 27668537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
    Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
    Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive role of Viola odorata extract on malignant characters of mammosphere-derived breast cancer stem cells.
    Yousefnia S; Naseri D; Seyed Forootan F; Tabatabaeian M; Moattar F; Ghafghazi T; Nasr Esfahani MH; Ghaedi K
    Clin Transl Oncol; 2020 Sep; 22(9):1619-1634. PubMed ID: 32056127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.
    Duru N; Fan M; Candas D; Menaa C; Liu HC; Nantajit D; Wen Y; Xiao K; Eldridge A; Chromy BA; Li S; Spitz DR; Lam KS; Wicha MS; Li JJ
    Clin Cancer Res; 2012 Dec; 18(24):6634-47. PubMed ID: 23091114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of extracellular alkalinization on the survival of human CD24-/CD44+ breast cancer stem cells associated with cellular metabolic shifts.
    Wanandi SI; Yustisia I; Neolaka GMG; Jusman SWA
    Braz J Med Biol Res; 2017 Jul; 50(8):e6538. PubMed ID: 28746471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 as a promising chemoresistance biomarker associated with the CD44
    Moreira MP; da Conceição Braga L; Cassali GD; Silva LM
    Exp Cell Res; 2018 Feb; 363(2):283-290. PubMed ID: 29352988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
    Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
    Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
    Piggott L; Omidvar N; Martí Pérez S; French R; Eberl M; Clarkson RW
    Breast Cancer Res; 2011 Sep; 13(5):R88. PubMed ID: 21914219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SURVIVIN as a marker for quiescent-breast cancer stem cells-An intermediate, adherent, pre-requisite phase of breast cancer metastasis.
    Siddharth S; Das S; Nayak A; Kundu CN
    Clin Exp Metastasis; 2016 Oct; 33(7):661-75. PubMed ID: 27411340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
    Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
    Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
    Lin QY; Wang JQ; Wu LL; Zheng WE; Chen PR
    Breast Cancer; 2020 Jan; 27(1):147-158. PubMed ID: 31410735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
    Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
    Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells.
    Aztopal N; Erkisa M; Erturk E; Ulukaya E; Tokullugil AH; Ari F
    Chem Biol Interact; 2018 Jan; 280():51-58. PubMed ID: 29225137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective Targeting Survivin, Caspase-3 and MicroRNA-16-1 Expression by Methyl-3-pentyl-6-methoxyprodigiosene Triggers Apoptosis in Colorectal Cancer Stem-Like Cells.
    Sam S; Sam MR; Esmaeillou M; Safaralizadeh R
    Pathol Oncol Res; 2016 Oct; 22(4):715-23. PubMed ID: 27055667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast cancer and benign stem/progenitor cell populations.
    Schillace RV; Skinner AM; Pommier RF; O'Neill S; Muller PJ; Naik AM; Hansen JE; Pommier SJ
    BMC Cancer; 2014 Sep; 14():733. PubMed ID: 25269750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.